Market Tracker

02/17 5:16pm ET

BIOLASE Inc (NASDAQ:BIOL)

1.53
Delayed Data
As of Feb 17
 +0.02 / +1.32%
Today’s Change
0.78
Today|||52-Week Range
1.98
+9.29%
Year-to-Date
Mafia, Guns, And Clans: The Big Libyan Oil Heist
Feb 13 / Investing Channel - Paid Partner Content
 

Today’s Trading

Previous close1.51
Today’s open1.51
Day’s range1.50 - 1.53
Volume74,390
Average volume (3 months)133,634
Market cap$103.4M
Dividend yield--
Data as of 4:00pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+22.22%
Earnings growth (this year)+60.00%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+1.62%
P/E ratioNM
Price/Sales1.02
Price/Book3.57

Competitors

 Today’s
change
Today’s
% change
MLSSMilestone Scientific...0.000.00%
PDEXPro-Dex Inc-0.20-3.77%
ALGNAlign Technology Inc+1.34+1.34%
XRAYDentsply Sirona Inc+1.94+3.19%
Data as of 4:00pm ET, 02/17/2017

Financials

Next reporting dateMarch 8, 2017
EPS forecast (this quarter)$0.02
Annual revenue (last year)$48.1M
Annual profit (last year)-$20.3M
Net profit margin-42.15%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Harold C. Flynn
Vice President-
Operations
Richard R. Whipp
Corporate headquarters
Irvine, California

Forecasts